Structural basis of noscapine activation for tubulin binding

dc.contributor.authorCanales Mayordomo, María Ángeles
dc.contributor.authorBargsten, Katja
dc.contributor.authorBennani, Youssef L.
dc.contributor.authorDíaz, Fernando J.
dc.contributor.authorJiménez Barbero, Jesús
dc.contributor.authorOliva, María A.
dc.contributor.authorProta, Andrea E.
dc.contributor.authorRodríguez Salarichs, J.
dc.contributor.authorSteinmetz, Michel O.
dc.date.accessioned2026-01-13T08:04:28Z
dc.date.available2026-01-13T08:04:28Z
dc.date.issued2020-08-13
dc.description.abstractNoscapine is a natural alkaloid that is used as an antitussive medicine. However, it also acts as a weak anticancer agent in certain in vivo models through a mechanism that is largely unknown. Here, we performed structural studies and show that the cytotoxic agent 7A-O-demethoxy-amino-noscapine (7A-aminonoscapine) binds to the colchicine site of tubulin. We suggest that the 7A-methoxy group of noscapine prevents binding to tubulin due to a steric clash of the compound with the T5-loop of α-tubulin. We further propose that the anticancer activity of noscapine arises from a bioactive metabolite that binds to the colchicine site of tubulin to induce mitotic arrest through a microtubule cytoskeleton-based mechanism.
dc.description.departmentDepto. de Química Orgánica
dc.description.facultyFac. de Ciencias Químicas
dc.description.refereedTRUE
dc.description.sponsorshipAgencia española de investigación
dc.description.sponsorshipInstituto de la Salud Carlos III
dc.description.sponsorshipSwiss National Science Foundation (SNSF)
dc.description.statuspub
dc.identifier.citationOliva M A, Prota A E, Rodríguez-Salarichs J, Bennani Y L, Jiménez-Barbero J, Bargsten K, Canales A, Steinmetz M O, Fernando Díaz J, Structural Basis of Noscapine Activation for Tubulin Binding. J. Med. Chem. 2020, 63, 15, 8495–8501
dc.identifier.doi10.1021/acs.jmedchem.0c00855
dc.identifier.officialurlhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00855
dc.identifier.relatedurlhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00855
dc.identifier.urihttps://hdl.handle.net/20.500.14352/129977
dc.issue.number15
dc.journal.titleJournal of Medicinal Chemistry
dc.language.isoeng
dc.page.final8501
dc.page.initial8495
dc.publisherACS publications
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-104545RB-I00/ES/BASES ESTRUCTURALES DE LA NEUROTOXICIDAD POR ANTITUMORALES DIRIGIDOS CONTRA TUBULINA: HACIA MEJORES MODULADORES DE MICROTUBULOS CONTRA CANCER Y ENFERMEDADES NEURODEGENERATIVAS/
dc.relation.projectID/CTQ2016-76263-P
dc.relation.projectID/COV20-01007
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsrestricted access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu547
dc.subject.keywordMatrix CORCEMA analysis
dc.subject.keywordComplete relaxation
dc.subject.keywordColchicine
dc.subject.keywordMechanism
dc.subject.ucmCiencias
dc.subject.unesco23 Química
dc.titleStructural basis of noscapine activation for tubulin binding
dc.typejournal article
dc.type.hasVersionP
dc.volume.number63
dspace.entity.typePublication
relation.isAuthorOfPublication6cef3cac-1f82-4cba-aaa4-4c246752b0ba
relation.isAuthorOfPublication.latestForDiscovery6cef3cac-1f82-4cba-aaa4-4c246752b0ba

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JMedChemproof.pdf
Size:
4.21 MB
Format:
Adobe Portable Document Format

Collections